Effect of atenolol and enalapril treatment on oxidative stress parameters in patients with essential hypertension

Shashank Deoghare, N. D. Kantharia

Abstract


Background: Oxidative stress has emerged as an importantfactor in the pathophysiologyof hypertension. It alsocontributes to variouscomplicationsassociated with hypertension like vascular injury, atherosclerosis, renal dysfunction, and hypertensive end-organ damage. Present study was done to evaluate the effect of atenololand enalapril, twocommonly prescribed antihypertensive drugs, on oxidative stress in patients with hypertension.

Method: Sixty newly diagnosed hypertensive patients wererandomlyassigned to either atenolol (n = 30) or enalapriltherapy(n = 30) and followed up forthe period ofthree months. Twenty normotensive healthy volunteers served as control.Plasma malondialdehyde, superoxide dismutase and catalaselevelswere measuredat the time of enrollment and at the end of three months of antihypertensive treatment.

Results: Plasmamalondialdehyde was significantly increased whereas superoxide dismutase and catalase were significantly reduced in newly diagnosed hypertensive patients compared to controls. After three months of enalapril therapy, plasmamalondialdehydewassignificantly reduced and superoxide dismutase and catalase were significantlyelevated. Atenolol therapyhad no effect on theseoxidative stress parameters.

Conclusions: Enalapril therapy significantly reduced oxidative stress in contrast toatenolol.Thus enalapriltherapymay prove beneficial compared to atenolol bypreventing oxidative stressand related complications inhypertension in view of life long therapy required for the treatment of hypertension.


Keywords


Oxidative stress, Reactive oxygen species, Atenolol, Enalapril, Essential hypertension

Full Text:

PDF

References


Opari1 S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med 2003;139:761-76.

Savoia C, Schiffrin EL. Inflammation in hypertension. Curr Opin Nephrol Hypertens 2006;15:152-8.

Hamilton CA, Miller WH, Al-Benna S, Brosnan MJ, Drummond RD, McBride MW, Dominiczak AF. Strategies to reduce oxidative stress in cardiovascular disease. Clin Sci (Lond) 2004;106:219-34.

Asayama K, Dobashi K, Hayashibe H, Kato K. Effects of beta-adrenergic blockers with different ancillary properties on lipid peroxidation in hyperthyroid rat cardiac muscle. Endocrinologia Japonica 1989;36:687-94.

Zhang C, Xie HH, Lu ZA, Zhu MJ, Su DF. Inhibition of inflammation contributes to organ protection of atenolol in sinoaortic-denervated rats. J Cardiovasc Pharmacol 2004;43:663-8.

Pasini AF, Garbin U, Nava MC, Stranieri C, Davoli A, Sawamura T, et al. Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation. J Hypertens 2005;23:589-96.

Guoxiong C, Jun PU, Chentai Z, Yexin MA, Zaiying LU. Effects of β-blockers on the oxidative stress in the atherosclerotic rabbit. Journal of Clinical Cardiology. 2007-12.

Rugale C, Cordaillat M, Mimuran A, Jover B. Prevention and reversal by enalapril of target organ damage in angiotensin II hypertension. J Renin Angiotensin Aldosterone Syst 2005;6:154-60.

de Cavanagh EMV, Inserra F, Ferder L, Fraga C. Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues. Am J Physiol 2000;278:R572.

Napoli C, Sica V, de Nigris F, Pignalosa O, Condorelli M, Ignarro LJ, Liguori A. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Am Heart J 2004;148:e5.

Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.

Marklund S, Marklund G. Involvement of superoxide anion radical in the autoxidation of pyrogallol and a convenient assay of superoxide dismutase. Eur J Biochem 1974;47:469-76.

Nandi A, Chatterjee IB. Assay of superoxide dismutase activity in animal tissue. J Bio Sci 1988;13:305-15.

Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972;47:389-94.

M Touyz RM, Briones AM. Reactive oxygen species and vascular biology: implications in human hypertension. Hypertens Res 2011;34:5-14.

Park YM, Lim BH, Touyz RM, Park JB. Expression of NAD(P)H Oxidase Subunits and Their Contribution to Cardiovascular Damage in Aldosterone/Salt-Induced Hypertensive Rat. J Korean Med Sci 2008;23:1039-45.

Armas-Padilla MC, Armas-Hernandez MJ, Sosa-Canache B, Cammarata R, Pacheco B, Guerrero J, et al. Nitric oxide and malondialdehyde in human hypertension. Am J Ther 2007;14:172-6.

Djordjevic VB, Pavlovic D, Pejovic M, Cvetkovic T, Lecic N, Deljanin-Ilic M. Changes of lipid peroxides and antioxidative factor levels in blood of patients treated with ACE inhibitors. Clin Nephrol 1997;47:243-7.

Touyz RM, Yao G, Schiffrin EL. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003;23:981-7.

Hosomi N, Mizushige K, Ohyama H, Takahashi T, Kitadai M, Hatanaka Y, et al. Angiotensin-converting enzyme inhibition with enalapril slows progressive intima-media thickening of the common carotid artery in patients with non–insulin-dependent diabetes mellitus. Stroke 2001;32:1539-45.

Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003;111:1201-9.

Landmesser U, Spiekermann S, Preuss C, et al. Angiotensin II induces endothelial xanthine oxidase activation. Role for endothelial dysfunction in patients with coronary disease. Arterioscler Thromb Vasc Biol 2007;27:943-8.

Brandes RP. A new pixel in the puzzle. How increased vascular pressure induces oxidative stress. Hypertension 2009;54:964-7.

Mason RP, Kubant R, Jacob RF, et al. Effect of nebivolol on endothelial NO and peroxynitrite release in hypertensive animals: Role of antioxidant activity. J Cardiovasc Pharmacol 2006;48:862-9.

Groot AA, Mathy MJ, van Zwieten PA, et al. Antioxidant activity of nebivolol in the rat aorta. J Cardiovasc Pharmacol 2004;43:148-53.